Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Haleon missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its ...

The group, spun off from drugmaker GSK in 2022, said its Panadol painkiller ... with organic revenue up high-single digit as Sensodyne and parodontax continued to drive growth.' ...

By Yamini Kalia (Reuters) -Haleon missed third-quarter revenue and profit expectations on Thursday, partly hurt by a stronger ...

(Reuters) -Haleon posted an unexpected drop in third-quarter revenue on Thursday, hurt by a weak demand for its painkiller in ...

Haleon--which houses Sensodyne toothpaste and Aquafresh mouthwash as well as over-the-counter medicines Panadol and Advil--posted organic revenue growth of 6.1%. The company had guided revenue growth ...

Haleon’s household names such as Sensodyne and Paradontax toothpastes helped drive group revenue to £2.78bn. (Photo Illustration by Christof Koepsel/Getty Images) Consumer healthcare company ...

GSK said it is mak­ing its largest man­u­fac­tur­ing in­vest­ment in the US yet, al­lo­cat­ing $800 mil­lion to up­grade its vac­cine pro­duc­tion site in Penn­syl­va­nia. … ...

GSK has made its largest-ever single manufacturing investment in the US. Image credit: Shutterstock/ Golden Shrimp. Following outlays for sites in the UK and Belgium earlier this year, GSK is planning ...

THE ARM FOR THE LANCASTER COUNTY ECONOMY. THIS IS FOR GSK, THE LARGEST INVESTMENT IN MANUFACTURING WE’VE EVER DONE IN THE UNITED STATES. THE $800 MILLION WILL BE USED TO EXPAND GSK’S MARIETTA ...